冷锅冒热气,近期创新药这把火越烧越旺,不断官宣的BD(Business Development,即业务拓展)交易是最直接的催化剂。继石药集团(01093.HK)首开先河以公告形式预告了BD交易后,荣昌生物(688331.SH)、中国生物制药(01177.HK)接力般地公布,将有BD交易展开或即将落地,中国生物制药资本市场负责人雷鸣更强调是“一笔标志性的重磅对外授权交易”。6月13日,石药集团的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.